A new market analysis projects the Heart Block Therapeutics Market will grow from an estimated USD 3.5 billion in 2025 to a ...

As a teenager, Simon lost everything. Now a multi-millionaire entrepreneur, he has some stunning advice for struggling ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...

Before the Kansas City Chiefs became perennial Super Bowl contenders, Andy Reid led a textbook organizational turnaround.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the stocks Jim Cramer recently shed light on. When a caller noted that the ...

The report, from 340B Health, claims that changes proposed by major drugmakers to replace upfront discounts with post-sale rebates for outpatient drugs would hit safety-net hospitals with significant ...

Even though oncology segment revenue inched up just 1 percent year over year, the firm lifted full-year expectations slightly ...

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...